Role of lipid rafts in virus infection

Future Virology

Volumn 4, Issue 5, 2009, Pages 487-500

  Upla, Paula ^a   Hyypiä, Timo ^b   Marjomäki, Varpu ^a  

^a UNIVERSITY OF JYVÄSKYLÄ   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Assembly; Cellular signaling; Cholesterol; Endocytosis; Lipid raft; Membrane trafficking; Virus; Virus replication

Indexed keywords

ACTIN; CAVEOLIN 1; CHOLESTEROL; DYNAMIN; GUANOSINE TRIPHOSPHATASE; SPHINGOLIPID;

BIOGENESIS; CELL MEMBRANE; ENDOCYTOSIS; HOST CELL; INTERNALIZATION; LIPID RAFT; LIPID TRANSPORT; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; VIRUS ASSEMBLY; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS REPLICATION;

EID: 73849093278     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/fvl.09.45     Document Type: Review

References (166)

1. Simons K, Ikonen E: Functional rafts in cell membranes. Nature 387, 569-572 (1997).
2. Brown DA, London E: Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14, 111-136 (1998).
3. Kusumi A, Koyama-Honda I, Suzuki K: Molecular dynamics and interactions for creation of stimulation-induced stabilized rafts from small unstable steady-state rafts. Traffic 5, 213-230 (2004).
4. Schroeder R, London E, Brown D: Interactions between saturated acyl chains confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behavior. Proc. Natl Acad. Sci. USA 91, 12130-12134 (1994).
5. Brown DA, Rose JK: Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68, 533-544 (1992).
6. Chen J, Chen L, Wang G, Tang H: Cholesterol-dependent and -independent CD40 internalization and signaling activation in cardiovascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 27, 2005-2013 (2007).
7. Turner MS, Sens P, Socci ND: Nonequilibrium raftlike membrane domains under continuous recycling. Phys. Rev. Lett. 95, 168301 (2005).
8. Poloso NJ, Muntasell A, Roche PA: MHC class II molecules traffic into lipid rafts during intracellular transport. J. Immunol. 173, 4539-4546 (2004).
9. Montixi C, Langlet C, Bernard AM et al.: Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J. 17, 5334-5348 (1998).
10. Insel PA, Head BP, Patel HH, Roth DM, Bundey RA, Swaney JS: Compartmentation of G-protein-coupled receptors and their signalling components in lipid rafts and caveolae. Biochem. Soc. Trans. 33, 1131-1134 (2005).
11. Oh P, Schnitzer JE: Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol. Biol. Cell 12, 685-698 (2001).
12. Holowka D, Gosse JA, Hammond AT et al.: Lipid segregation and IgE receptor signaling: a decade of progress. Biochim. Biophys. Acta 1746, 252-259 (2005).
13. Gombos I, Kiss E, Detre C, Laszlo G, Matko J: Cholesterol and sphingolipids as lipid organizers of the immune cells' plasma membrane: their impact on the functions of MHC molecules, effector T-lymphocytes and T-cell death. Immunol. Lett. 104, 59-69 (2006).
14. Gombos I, Detre C, Vamosi G, Matko J: Rafting MHC-II domains in the APC (presynaptic) plasma membrane and the thresholds for T-cell activation and immunological synapse formation. Immunol. Lett. 92, 117-124 (2004).
15. Fox TE, Houck KL, O'Neill SM et al.: Ceramide recruits and activates protein kinase Cζ (PKCζ) within structured membrane microdomains. J. Biol. Chem. 282, 12450-12457 (2007).
16. Harder T: Formation of functional cell membrane domains: the interplay of lipid-and protein-mediated interactions. Philos. Trans. R. Soc. Lond. B Biol. Sci. 358, 863-868 (2003).
17. Gaus K, Le Lay S, Balasubramanian N, Schwartz MA: Integrin-mediated adhesion regulates membrane order. J. Cell Biol. 174, 725-734 (2006).
18. Munro S: Lipid rafts: elusive or illusive? Cell 115, 377-388 (2003).
19. Shaw AS: Lipid rafts: now you see them, now you don't. Nat. Immunol. 7, 1139-1142 (2006).
20. Lingwood D, Simons K: Detergent resistance as a tool in membrane research. Nat. Protoc. 2, 2159-2165 (2007).
21. Gombos I, Steinbach G, Pomozi I et al.: Some new faces of membrane microdomains: a complex confocal fluorescence, differential polarization, and FCS imaging study on live immune cells. Cytometry A 73, 220-229 (2008).
22. Ritchie K, Kusumi A: Role of the membrane skeleton in creation of microdomains. Subcell. Biochem. 37, 233-245 (2004).
23. del Pozo MA, Alderson NB, Kiosses WB, Chiang HH, Anderson RG, Schwartz MA: Integrins regulate Rac targeting by internalization of membrane domains. Science 303, 839-842 (2004). ■■ Shows regulation of rafts by integrin in adhesion-dependent cells.
24. Wu YT, Zhang S, Kim YS et al.: Signaling pathways from membrane lipid rafts to JNK1 activation in reactive nitrogen species-induced non-apoptotic cell death. Cell Death Differ. 15, 386-397 (2008).
25. Mineo C, Ying YS, Chapline C, Jaken S, Anderson RG: Targeting of protein kinase Cα to caveolae. J. Cell Biol. 141, 601-610 (1998).
26. 2+ wave propagation in glial cells. Cell Calcium 41, 155-167 (2007).
27. Resh MD: Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim. Biophys. Acta 1451, 1-16 (1999).
28. de Diesbach P, Medts T, Carpentier S et al.: Differential subcellular membrane recruitment of Src may specify its downstream signalling. Exp. Cell Res. 314, 1465-1479 (2008).
29. Weernink PA, Rijksen G: Activation and translocation of c-Src to the cytoskeleton by both platelet-derived growth factor and epidermal growth factor. J. Biol. Chem. 270, 2264-2267 (1995).
30. Roepstorff K, Thomsen P, Sandvig K, van Deurs B: Sequestration of epidermal growth factor receptors in non-caveolar lipid rafts inhibits ligand binding. J. Biol. Chem. 277, 18954-18960 (2002).
31. Frick M, Bright NA, Riento K, Bray A, Merrified C, Nichols BJ: Coassembly of flotillins induces formation of membrane microdomains, membrane curvature, and vesicle budding. Curr. Biol. 17, 1151-1156 (2007).
32. Schafer DA: Coupling actin dynamics and membrane dynamics during endocytosis. Curr. Opin. Cell Biol. 14, 76-81 (2002).
33. Pelkmans L, Fava E, Grabner H et al.: Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 436, 78-86 (2005).
34. Kirkham M, Parton RG: Clathrinindependent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. Biochim. Biophys. Acta 1745, 273-286 (2005).
35. Kirkham M, Fujita A, Chadda R et al.: Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles. J. Cell Biol. 168, 465-476 (2005).
36. Mayor S, Pagano RE: Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell. Biol. 8, 603-612 (2007).
37. Thomsen P, Roepstorff K, Stahlhut M, van Deurs B: Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking. Mol. Biol. Cell 13, 238-250 (2002).
38. Fra AM, Williamson E, Simons K, Parton RG: De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc. Natl Acad. Sci. USA 92, 8655-8659 (1995).
39. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG: Caveolin, a protein component of caveolae membrane coats. Cell 68, 673-682 (1992).
40. Hill MM, Bastiani M, Luetterforst R et al.: PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 132, 113-124 (2008). ■■ Identifies a protein needed for caveolae formation.
41. Lajoie P, Goetz JG, Dennis JW, Nabi IR: Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane. J. Cell Biol. 185, 381-385 (2009). ■ Update on membrane microdomains.
42. Richter T, Floetenmeyer M, Ferguson C et al.: High-resolution 3D quantitative analysis of caveolar ultrastructure and caveola-cytoskeleton interactions. Traffic 9, 893-909 (2008). ■■ Provides 3D information of caveolae.
43. Parton RG, Simons K: The multiple faces of caveolae. Nat. Rev. Mol. Cell. Biol. 8, 185-194 (2007).
44. Pilch PF, Souto RP, Liu L et al.: Cellular spelunking: exploring adipocyte caveolae. J. Lipid Res. 48, 2103-2111 (2007).
45. Sharma DK, Brown JC, Choudhury A et al.: Selective stimulation of caveolar endocytosis by glycosphingolipids and cholesterol. Mol. Biol. Cell 15, 3114-3122 (2004).
46. Parton RG, Joggerst B, Simons K: Regulated internalization of caveolae. J. Cell Biol. 127, 1199-1215 (1994).
47. Kiss AL, Botos E, Turi A, Mullner N: Ocadaic acid treatment causes tyrosine phosphorylation of caveolin-2 and induces internalization of caveolae in rat peritoneal macrophages. Micron 35, 707-715 (2004).
48. Kiss AL, Botos E: Ocadaic acid retains caveolae in multicaveolar clusters. Pathol. Oncol. Res. (2009) (Epub ahead of print).
49. Mundy DI, Machleidt T, Ying YS, Anderson RG, Bloom GS: Dual control of caveolar membrane traffic by microtubules and the actin cytoskeleton. J. Cell Sci. 115, 4327-4339 (2002).
50. van Deurs B, Roepstorff K, Hommelgaard AM, Sandvig K: Caveolae: anchored, multifunctional platforms in the lipid ocean. Trends Cell. Biol. 13, 92-100 (2003).
51. Minshall RD, Tiruppathi C, Vogel SM et al.: Endothelial cell-surface gp60 activates vesicle formation and trafficking via G(i)-coupled Src kinase signaling pathway. J. Cell Biol. 150, 1057-1070 (2000).
52. Sverdlov M, Shajahan AN, Minshall RD: Tyrosine phosphorylation-dependence of caveolae-mediated endocytosis. J. Cell. Mol. Med. 11, 1239-1250 (2007).
53. Oh P, McIntosh DP, Schnitzer JE: Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J. Cell Biol. 141, 101-114 (1998).
54. Pelkmans L, Kartenbeck J, Helenius A: Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 3, 473-483 (2001).
55. Nichols BJ: A distinct class of endosome mediates clathrin-independent endocytosis to the Golgi complex. Nat. Cell Biol. 4, 374-378 (2002).
56. Pietiäinen V, Marjomäki V, Upla P, Pelkmans L, Helenius A, Hyypiä T: Echovirus 1 endocytosis into caveosomes requires lipid rafts, dynamin II, and signaling events. Mol. Biol. Cell 15, 4911-4925 (2004).
57. Marjomäki V, Pietiäinen V, Matilainen H et al.: Internalization of echovirus 1 in caveolae. J. Virol. 76, 1856-1865 (2002).
58. Pelkmans L, Burli T, Zerial M, Helenius A: Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell 118, 767-780 (2004).
59. Heasman SJ, Ridley AJ: Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat. Rev. Mol. Cell Biol. 9, 690-701 (2008).
60. Lamaze C, Dujeancourt A, Baba T, Lo CG, Benmerah A, Dautry-Varsat A: Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol. Cell 7, 661-671 (2001).
61. Grassart A, Dujeancourt A, Lazarow PB, Dautry-Varsat A, Sauvonnet N: Clathrin-independent endocytosis used by the IL-2 receptor is regulated by Rac1, Pak1 and Pak2. EMBO Rep. 9, 356-362 (2008).
62. Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L: A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367, 40-46 (1994).
63. Dharmawardhane S, Schurmann A, Sells MA, Chernoff J, Schmid SL, Bokoch GM: Regulation of macropinocytosis by p21-activated kinase-1. Mol. Biol. Cell 11, 3341-3352 (2000).
64. Sauvonnet N, Dujeancourt A, Dautry-Varsat A: Cortactin and dynamin are required for the clathrin-independent endocytosis of γc cytokine receptor. J. Cell. Biol. 168, 155-163 (2005).
65. Hall A: Rho GTPases and the actin cytoskeleton. Science 279, 509-514 (1998).
66. Van Aelst L, D'Souza-Schorey C: Rho GTPases and signaling networks. Genes Dev. 11, 2295-2322 (1997).
67. D'Souza-Schorey C, Chavrier P: ARF proteins: roles in membrane traffic and beyond. Nat. Rev. Mol. Cell. Biol. 7, 347-358 (2006).
68. Lundmark R, Doherty GJ, Howes MT et al.: The GTPase-activating protein GRAF1 regulates the CLIC/GEEC endocytic pathway. Curr. Biol. 18, 1802-1808 (2008). γ Provides the first noncargo marker for clathrin-independent carrier/GPI-anchored, protein-enriched early endosomal compartment endocytic membranes.
69. Kumari S, Mayor S: ARF1 is directly involved in dynamin-independent endocytosis. Nat. Cell Biol. 10, 30-41 (2008).
70. Kalia M, Kumari S, Chadda R, Hill MM, Parton RG, Mayor S: Arf6-independent GPI-anchored protein-enriched early endosomal compartments fuse with sorting endosomes via a Rab5/ phosphatidylinositol-3́-kinase- dependent machinery. Mol. Biol. Cell 17, 3689-3704 (2006).
71. Sabharanjak S, Sharma P, Parton RG, Mayor S: GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev. Cell 2, 411-423 (2002).
72. Chadda R, Howes MT, Plowman SJ, Hancock JF, Parton RG, Mayor S: Cholesterol-sensitive Cdc42 activation regulates actin polymerization for endocytosis via the GEEC pathway. Traffic 8, 702-717 (2007).
73. Bonazzi M, Spano S, Turacchio G et al.: CtBP3/BARS drives membrane fission in dynamin-independent transport pathways. Nat. Cell Biol. 7, 570-580 (2005).
74. Fivaz M, Vilbois F, Thurnheer S et al.: Differential sorting and fate of endocytosed GPI-anchored proteins. EMBO J. 21, 3989-4000 (2002).
75. Babuke T, Tikkanen R: Dissecting the molecular function of reggie/flotillin proteins. Eur. J. Cell. Biol. 86, 525-532 (2007).
76. Glebov OO, Bright NA, Nichols BJ: Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat. Cell Biol. 8, 46-54 (2006).
77. Naslavsky N, Weigert R, Donaldson JG: Convergence of non-clathrin- and clathrin-derived endosomes involves Arf6 inactivation and changes in phosphoinositides. Mol. Biol. Cell 14, 417-431 (2003).
78. Naslavsky N, Weigert R, Donaldson JG: Characterization of a nonclathrin endocytic pathway: membrane cargo and lipid requirements. Mol. Biol. Cell 15, 3542-3552 (2004).
79. Powelka AM, Sun J, Li J et al.: Stimulation-dependent recycling of integrin β1 regulated by ARF6 and Rab11. Traffic 5, 20-36 (2004).
80. Brown FD, Rozelle AL, Yin HL, Balla T, Donaldson JG: Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J. Cell Biol. 154, 1007-1017 (2001).
81. Barral DC, Cavallari M, McCormick PJ et al.: CD1a and MHC class I follow a similar endocytic recycling pathway. Traffic 9, 1446-1457 (2008).
82. Karacsonyi C, Miguel AS, Puertollano R: Mucolipin-2 localizes to the Arf6-associated pathway and regulates recycling of GPI-APs. Traffic 8, 1404-1414 (2007).
83. Lau AW, Chou MM: The adaptor complex AP-2 regulates post-endocytic trafficking through the non-clathrin Arf6-dependent endocytic pathway. J. Cell Sci. 121, 4008-4017 (2008).
84. Rodal SK, Skretting G, Garred O, Vilhardt F, van Deurs B, Sandvig K: Extraction of cholesterol with methyl-β-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol. Biol. Cell 10, 961-974 (1999).
85. Sobo K, Chevallier J, Parton RG, Gruenberg J, van der Goot FG: Diversity of raft-like domains in late endosomes. PLoS ONE 2, e391 (2007).
86. Deng H, Liu R, Ellmeier W et al.: Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666 (1996).
87. Gallo SA, Finnegan CM, Viard M et al.: The HIV Env-mediated fusion reaction. Biochim. Biophys. Acta 1614, 36-50 (2003).
88. Doms RW, Trono D: The plasma membrane as a combat zone in the HIV battlefield. Genes Dev 14, 2677-2688 (2000).
89. Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB: HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 137, 433-444 (2009). ■■ Shows the fusion reaction of HIV-1 in endosomes after endocytic entry.
90. + T cells. J. Virol. 76, 4709-4722 (2002).
91. Kozak SL, Heard JM, Kabat D: Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus. J. Virol. 76, 1802-1815 (2002).
92. Manes S, del Real G, Lacalle RA et al.: Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep. 1, 190-196 (2000).
93. Carter GC, Bernstone L, Sangani D, Bee JW, Harder T, James W: HIV entry in macrophages is dependent on intact lipid rafts. Virology 386(1), 192-202 (2009).
94. Kamiyama H, Yoshii H, Tanaka Y, Sato H, Yamamoto N, Kubo Y: Raft localization of CXCR4 is primarily required for X4-tropic human immunodeficiency virus type 1 infection. Virology 386, 23-31 (2009).
95. Percherancier Y, Lagane B, Planchenault T et al.: HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains. J. Biol. Chem. 278, 3153-3161 (2003).
96. Viard M, Parolini I, Sargiacomo M et al.: Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells. J. Virol. 76, 11584-11595 (2002).
97. Guyader M, Kiyokawa E, Abrami L, Turelli P, Trono D: Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization. J. Virol. 76, 10356-10364 (2002).
98. Liao Z, Cimakasky LM, Hampton R, Nguyen DH, Hildreth JE: Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res. Hum. Retroviruses 17, 1009-1019 (2001).
99. Ablan S, Rawat SS, Viard M, Wang JM, Puri A, Blumenthal R: The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion. Virol. J. 3, 104 (2006).
100. Chung CS, Huang CY, Chang W: Vaccinia virus penetration requires cholesterol and results in specific viral envelope proteins associated with lipid rafts. J. Virol. 79, 1623-1634 (2005).
101. Mercer J, Helenius A: Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320, 531-535 (2008). ■■ Describes how viruses can use apoptosis for promoting infection.
102. Huang CY, Lu TY, Bair CH, Chang YS, Jwo JK, Chang W: A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis. J. Virol. 82, 7988-7999 (2008). ■ Describes a novel cellular protein in vaccinia virus entry.
103. Spear PG, Eisenberg RJ, Cohen GH: Three classes of cell surface receptors for aherpesvirus entry. Virology 275, 1-8 (2000).
104. Bender FC, Whitbeck JC, Ponce de Leon M, Lou H, Eisenberg RJ, Cohen GH: Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry. J. Virol. 77, 9542-9552 (2003).
105. Raghu H, Sharma-Walia N, Veettil MV et al.: Lipid rafts of primary endothelial cells are essential for Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-induced phosphatidylinositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear delivery of viral DNA but dispensable for binding and entry. J. Virol. 81, 7941-7959 (2007).
106. Tang H, Kawabata A, Takemoto M, Yamanishi K, Mori Y: Human herpesvirus-6 infection induces the reorganization of membrane microdomains in target cells, which are required for virus entry. Virology 378, 265-271 (2008).
107. Li W, Moore MJ, Vasilieva N et al.: Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450-454 (2003).
108. Wang H, Yang P, Liu K et al.: SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res. 18, 290-301 (2008).
109. Li GM, Li YG, Yamate M, Li SM, Ikuta K: Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle. Microbes Infect. 9, 96-102 (2007).
110. Empig CJ, Goldsmith MA: Association of the caveola vesicular system with cellular entry by filoviruses. J. Virol. 76, 5266-5270 (2002).
111. Bavari S, Bosio CM, Wiegand E et al.: Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J. Exp. Med. 195, 593-602 (2002).
112. Saeed MF, Kolokoltsov AA, Freiberg AN, Holbrook MR, Davey RA: Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus. PLoS Pathog. 4, e1000141 (2008).
113. Yonezawa A, Cavrois M, Greene WC: Studies of Ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor α. J. Virol. 79, 918-926 (2005).
114. Medigeshi GR, Hirsch AJ, Streblow DN, Nikolich-Zugich J, Nelson JA: West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of αvβ3 integrin. J. Virol. 82, 5212-5219 (2008).
115. Brandenburg B, Lee LY, Lakadamyali M, Rust MJ, Zhuang X, Hogle JM: Imaging poliovirus entry in live cells. PLoS Biol. 5, e183 (2007).
116. Anderson HA, Chen Y, Norkin LC: Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol. Biol. Cell 7, 1825-1834 (1996).
117. Norkin LC, Anderson HA, Wolfrom SA, Oppenheim A: Caveolar endocytosis of simian virus 40 is followed by brefeldin A-sensitive transport to the endoplasmic reticulum, where the virus disassembles. J. Virol. 76, 5156-5166 (2002).
118. Tsai B, Gilbert JM, Stehle T, Lencer W, Benjamin TL, Rapoport TA: Gangliosides are receptors for murine polyoma virus and SV40. EMBO J. 22, 4346-4355 (2003).
119. Pelkmans L, Zerial M: Kinase-regulated quantal assemblies and kiss-and-run recycling of caveolae. Nature 436, 128-133 (2005).
120. Pelkmans L, Puntener D, Helenius A: Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 296, 535-539 (2002).
121. Damm EM, Pelkmans L, Kartenbeck J, Mezzacasa A, Kurzchalia T, Helenius A: Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J. Cell Biol. 168, 477-488 (2005). ■ Shows how different entry routes for a virus can operate simultaneously.
122. Xing L, Huhtala M, Pietiäinen V et al.: Structural and functional analysis of integrin α2I domain interaction with echovirus 1. J. Biol. Chem. 279, 11632-11638 (2004).
123. Upla P, Marjomäki V, Kankaanpää P et al.: Clustering induces a lateral redistribution of α2β1 integrin from membrane rafts to caveolae and subsequent protein kinase C-dependent internalization. Mol. Biol. Cell 15, 625-636 (2004).
124. Karjalainen M, Kakkonen E, Upla P et al.: A raft-derived, Pak1-regulated entry participates in α2β1 integrin-dependent sorting to caveosomes. Mol. Biol. Cell 19, 2857-2869 (2008).
125. Liberali P, Kakkonen E, Turacchio G et al.: The closure of Pak1-dependent macropinosomes requires the phosphorylation of CtBP1/BARS. EMBO J. 27, 970-981 (2008).
126. Upla P, Marjomäki V, Nissinen L et al.: Calpain 1 and 2 are required for RNA replication of echovirus 1. J. Virol. 82, 1581-1590 (2008).
127. O'Donnell V, Larocco M, Baxt B: Heparan sulfate-binding foot-and-mouth disease virus enters cells via caveola-mediated endocytosis. J. Virol. 82, 9075-9085 (2008).
128. Stuart AD, Eustace HE, TA McKee, Brown TD: A novel cell entry pathway for a DAF-using human enterovirus is dependent on lipid rafts. J. Virol. 76, 9307-9322 (2002).
129. Coyne CB, Kim KS, Bergelson JM: Poliovirus entry into human brain microvascular cells requires receptor-induced activation of SHP-2. EMBO J. 26, 4016-4028 (2007). ■ Interesting article on poliovirus entry.
130. Shafren DR: Viral cell entry induced by cross-linked decay-accelerating factor. J. Virol. 72, 9407-9412 (1998).
131. Triantafilou K, Triantafilou M: Coxsackievirus B4-induced cytokine production in pancreatic cells is mediated through Toll-like receptor 4. J. Virol. 78, 11313-11320 (2004).
132. Triantafilou K, Triantafilou M: Lipid-raft-dependent Coxsackievirus B4 internalization and rapid targeting to the Golgi. Virology 326, 6-19 (2004).
133. Triantafilou K, Triantafilou M: Lipid raft microdomains: key sites for Coxsackievirus A9 infectious cycle. Virology 317, 128-135 (2003).
134. Isa P, Realpe M, Romero P, Lopez S, Arias CF: Rotavirus RRV associates with lipid membrane microdomains during cell entry. Virology 322, 370-381 (2004).
135. Eash S, Querbes W, Atwood WJ: Infection of vero cells by BK virus is dependent on caveolae. J. Virol. 78, 11583-11590 (2004).
136. Jackson WT, Giddings TH Jr, Taylor MP et al.: Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol. 3, e156 (2005).
137. Aizaki H, Lee KJ, Sung VM, Ishiko H, Lai MM: Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology 324, 450-461 (2004).
138. Shi ST, Lee KJ, Aizaki H, Hwang SB, Lai MM: Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J. Virol. 77, 4160-4168 (2003).
139. Lee CJ, Lin HR, Liao CL, Lin YL: Cholesterol effectively blocks entry of flavivirus. J. Virol. 82, 6470-6480 (2008).
140. Noisakran S, Dechtawewat T, Avirutnan P et al.: Association of dengue virus NS1 protein with lipid rafts. J. Gen. Virol. 89, 2492-2500 (2008).
141. Aloia RC, Tian H, Jensen FC: Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl Acad. Sci. USA 90, 5181-5185 (1993).
142. Brugger B, Glass B, Haberkant P, Leibrecht I, Wieland FT, Krausslich HG: The HIV lipidome: a raft with an unusual composition. Proc. Natl Acad. Sci. USA 103, 2641-2646 (2006).
143. Ott DE: Cellular proteins in HIV virions. Rev. Med. Virol. 7, 167-180 (1997).
144. Ono A, Freed EO: Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl Acad. Sci. USA 98, 13925-13930 (2001).
145. Lindwasser OW, Resh MD: Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding. Proc. Natl Acad. Sci. USA 99, 13037-13042 (2002).
146. Freed EO, Martin MA: Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70, 341-351 (1996).
147. Ding L, Derdowski A, Wang JJ, Spearman P: Independent segregation of human immunodeficiency virus type 1 Gag protein complexes and lipid rafts. J. Virol. 77, 1916-1926 (2003).
148. Waheed AA, Freed EO: Lipids and membrane microdomains in HIV-1 replication. Virus Res. (2009) (Epub ahead of print). ■ Update on HIV-1 replication and lipid microdomains.
149. Freed EO: HIV-1 Gag: flipped out for PI(4,5) P(2). Proc. Natl Acad. Sci. USA 103, 11101-11102 (2006).
150. Chan R, Uchil PD, Jin J et al.: Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. J. Virol. 82, 11228-11238 (2008).
151. Bhattacharya J, Repik A, Clapham PR: Gag regulates association of human immunodeficiency virus type 1 envelope with detergent-resistant membranes. J. Virol. 80, 5292-5300 (2006).
152. Brugger B, Krautkramer E, Tibroni N et al.: Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains. Retrovirology 4, 70 (2007).
153. Jolly C, Sattentau QJ: Human immunodeficiency virus type 1 virological synapse formation in T cells requires lipid raft integrity. J. Virol. 79, 12088-12094 (2005).
154. Yeo DS, Chan R, Brown G et al.: Evidence that selective changes in the lipid composition of raft-membranes occur during respiratory syncytial virus infection. Virology 386, 168-182 (2009).
155. Fleming EH, Kolokoltsov AA, Davey RA, Nichols JE, Roberts NJ Jr: Respiratory syncytial virus F envelope protein associates with lipid rafts without a requirement for other virus proteins. J. Virol. 80, 12160-12170 (2006).
156. Brown G, Aitken J, Rixon HW, Sugrue RJ: Caveolin-1 is incorporated into mature respiratory syncytial virus particles during virus assembly on the surface of virus-infected cells. J. Gen. Virol. 83, 611-621 (2002).
157. Manie SN, de Breyne S, Vincent S, Gerlier D: Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly. J. Virol. 74, 305-311 (2000).
158. Vincent S, Gerlier D, Manie SN: Measles virus assembly within membrane rafts. J. Virol. 74, 9911-9915 (2000).
159. Panchal RG, Ruthel G, Kenny TA et al.: In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Proc. Natl Acad. Sci. USA 100, 15936-15941 (2003).
160. Ali A, Nayak DP: Assembly of Sendai virus: M protein interacts with F and HN proteins and with the cytoplasmic tail and transmembrane domain of F protein. Virology 276, 289-303 (2000).
161. Sapin C, Colard O, Delmas O et al.: Rafts promote assembly and atypical targeting of a nonenveloped virus, rotavirus, in Caco-2 cells. J. Virol. 76, 4591-4602 (2002).
162. Chwetzoff S, Trugnan G: Rotavirus assembly: an alternative model that utilizes an atypical trafficking pathway. Curr. Top. Microbiol. Immunol. 309, 245-261 (2006).
163. Mohan KV, Muller J, Atreya CD: Defective rotavirus particle assembly in lovastatin-treated MA104 cells. Arch. Virol. 153, 2283-2290 (2008).
164. Bhattacharya B, Roy P: Bluetongue virus outer capsid protein VP5 interacts with membrane lipid rafts via a SNARE domain. J. Virol. 82, 10600-10612 (2008).
165. Trinchero J, Ponce NM, Cordoba OL et al.: Antiretroviral activity of fucoidans extracted from the brown seaweed Adenocystis utricularis. Phytother. Res. 23, 707-712 (2009).
166. Smith AE, Helenius A: How viruses enter animal cells. Science 304, 237-242 (2004).